International Journal of Cardiology

International Journal of Cardiology is an Elsevier journal that has appeared since 1981 and covers cardiology in its broadest sense. It publishes translational, clinical and epidemiological research across cardiovascular medicine, and its 2025 impact factor is 3.3.《国际心脏病学杂志》是爱思唯尔出版的一份期刊，自 1981 年发行，覆盖最广义的心脏病学。该刊发表贯穿心血管医学的转化，临床与流行病学研究，2025 年影响因子为 3.3。

Scope

• The journal is devoted to cardiovascular health and disease, from biological mechanism and disease development to prevention, diagnosis and treatment.该刊致力于心血管健康与疾病，从生物学机制与疾病发展到预防，诊断与治疗。

• Outcomes and the delivery of care are named as subjects, so the journal is concerned with what happens to a patient as well as with a mechanism.结果与医疗服务的供给被列为选题，因此该刊既关注机制，也关注患者所发生的情况。

• It offers a broad international forum for translational research, and clinical and epidemiological work is taken as well.该刊为转化研究提供宽泛的国际论坛，临床与流行病学工作同样被接收。

• Studies that inform clinical decision-making are welcomed, since the journal serves people who treat patients.能为临床决策提供依据的研究受到欢迎，因为该刊服务于治疗患者的人。

• Work that evaluates a diagnostic approach is taken, and a paper may compare two ways of finding the same condition.评价某种诊断方法的工作会被接收，论文可以比较发现同一种疾病的两种方式。

• Therapeutic approaches are assessed, so a report of a trial has a place in the journal.治疗方法受到评估，因此试验报告在该刊有一席之地。

• Studies that advance patient care are placed at the centre of what the journal takes.能推进患者照护的研究被置于该刊所接收内容的核心。

• Papers that bring together experimental, clinical and imaging approaches are particularly welcome.把实验，临床与影像方法结合起来的研究尤其受欢迎。

• Physiological, computational and population-based methods are all named as approaches the journal likes to see joined.生理学，计算与基于人群的方法都被列为该刊乐见其结合的做法。

• Both basic research and clinical papers may be submitted, so the journal does not divide the laboratory from the ward.基础研究与临床论文都可以投稿，因此该刊并不把实验室与病房分开。

• Original research, consensus and position papers, systematic reviews and meta-analyses are among the article types it sets out.原创研究，共识与立场论文，系统综述与荟萃分析是该刊所列的文章类型。

• Brief reports are taken, but case reports are no longer accepted.短报告会被接收，但病例报告不再被接收。

• Editorials and review articles cover recent developments, so a reader is kept abreast of the field.社论与综述文章覆盖近期进展，因此读者得以紧跟该领域。

• Its readership bridges the practising clinician and the research worker, a position the journal has kept for decades.其读者群连结执业临床医生与研究者，这一取向该刊已保持数十年。

• Heart failure, arrhythmia and coronary disease are among the conditions its papers address.心力衰竭，心律失常与冠状动脉疾病是其论文所处理的状况之一。

• Congenital heart disease is covered, so work on the adult who was born with such a defect has a place.先天性心脏病也在覆盖之列，因此针对先天带此缺陷的成人的工作有其位置。

• Valvular disease and the imaging of the heart are studied together, since a picture guides the decision.瓣膜病与心脏成像被一并研究，因为图像引导决定。

• Preventive cardiology and cardiovascular risk are treated as subjects of their own.预防心脏病学与心血管风险本身被当作选题。

• The journal takes work on the epidemiology of cardiovascular disease, since population patterns inform policy.该刊接收心血管疾病流行病学方面的工作，因为人群格局为政策提供依据。

• Papers on the computational modelling of the circulation are welcome.循环系统的计算建模论文受到欢迎。

• The journal carries consensus documents that a society has agreed, since these guide practice.该刊载有经学会达成一致的共识文件，因为这些文件指导实践。

• Reports of registries and of large cohorts are taken, because a pattern shows up best across many patients.登记研究与大型队列的报告会被接收，因为格局在众多患者中显现得最清楚。

• The title is sold by subscription and also offers an open access route, so a paper may be read either way.该刊以订阅方式销售，也提供开放获取路径，因此论文可经由两种方式阅读。

• Its articles appear online before they are gathered into an issue.其文章在汇编成期之前先在网上出现。

• The journal keeps an archive that goes back to its first volume.该刊维护可回溯至其第一卷的档案。

• A paper may be accompanied by supplementary material that the authors deposit.论文可附有作者存放的补充材料。

• The editors publish a statement on the use of such tools as artificial intelligence.编辑公布一份人工智能等工具使用方面的声明。

• The journal is read by cardiologists in hospitals and by scientists in laboratories, and it tries to keep both audiences in view in every issue.医院里的心脏病科医生与实验室里的科学家都阅读该刊，该刊在每一期都力图兼顾两方读者。

• Papers on myocardial infarction, on hypertension and on the mechanisms of ischaemia are among the work the journal carries.心肌梗死，高血压与缺血机制方面的论文是该刊所载工作的一部分。

• Imaging studies are taken when they change what a clinician can see, and a paper may report a new way of measuring the heart.影像研究在改变临床医生所能看到的内容时会被接收，论文可以报告测量心脏的新方法。

• The journal has published work on cardiac surgery and on interventional procedures, so a paper need not be confined to internal medicine.该刊发表过心脏外科与介入操作方面的工作，因此论文不必局限于内科。

• The journal covers the whole span from prevention to rehabilitation, so a paper may sit at either end of that range.该刊覆盖从预防到康复的整个跨度，因此论文可以位于该范围的两端之一。

• It takes work on cardiovascular imaging, on biomarkers and on the devices that keep a failing heart working.该刊接收心血管影像，生物标志物以及维持衰竭心脏工作的器械方面的工作。

• A report on the quality of care that a health system delivers is taken, since outcomes depend on more than the therapy alone.某卫生体系所提供照护质量的报告会被接收，因为结果所依赖的不只是疗法本身。

• The journal has long carried editorials that frame a debate for its readers.该刊长期刊载为其读者框定一场争论的社论。

History

• The journal was founded in 1981, and it has appeared ever since.该刊创办于 1981 年，此后持续出版。

• It is published by Elsevier, through the house that was long known as Elsevier Ireland.该刊由爱思唯尔出版，经由长期以 Elsevier Ireland 为人所知的那家机构。

• Twenty-four issues appear in a year, so the title is semimonthly.该刊每年出版二十四期，因此为半月刊。

• The print number is 0167-5273 and the electronic number 1874-1754.其印本刊号为 0167-5273，电子刊号为 1874-1754。

• Its impact factor was 4.164 for 2021 and stood at 3.3 for 2025, with a five-year figure of 3.1.其影响因子 2021 年为 4.164，2025 年为 3.3，五年影响因子为 3.1。

• The title records a CiteScore of 6.4 and a long run of citations behind it.该刊的 CiteScore 为 6.4，其背后有长期的被引记录。

• It is indexed for MEDLINE and PubMed, and it appears in the Science Citation Index Expanded and in Scopus.该刊被 MEDLINE 与 PubMed 收录，并见于科学引文索引扩展版与 Scopus。

• Publication runs on a hybrid model, so an author may choose the open access route.出版采用混合模式，因此作者可以选择开放获取路径。

• The title belongs to a family of sibling journals that share its name, and their policies are announced together.该刊属于一个共用其名称的姊妹刊家族，它们的政策一并公布。

• A statement on the use of artificial intelligence sets out how such tools may be used in a manuscript.一份人工智能使用声明说明了此类工具在稿件中可以如何使用。

• The review of a paper takes about two months on average, as authors report.据作者反映，一篇论文的评审平均约需两个月。

Editors

• (Paolo G. Camici) is the editor-in-chief of the journal.（Paolo G. Camici）是该刊主编。

• He is a professor of cardiology at the Vita-Salute San Raffaele University in Milan.他是米兰圣拉斐尔生命健康大学的心脏病学教授。

• The journal is edited for Elsevier, and the editor works with a wide board of cardiologists.该刊为爱思唯尔编辑，主编与一个庞大的心脏病学编委会合作。

• Each manuscript is sent to reviewers who work on the subject it addresses.每篇稿件都被送给其主题领域的评审人。

• The editors receive the reports and take the decision on a paper.编辑收到报告后就论文作出决定。

• The journal office answers queries about submission and follows each paper.该刊办公室答复关于投稿的询问并跟踪每篇论文。

• The board covers the branches of cardiovascular medicine that the journal publishes.编委会覆盖该刊所发表的心血管医学各分支。

• Association editors handle the fields that sit beside cardiology but bear on it.副编辑处理位于心脏病学之旁却与之相关的领域。

• The editors state that a study is judged on whether it changes what a clinician would do.编辑声明一项研究据其是否改变临床医生的做法来评判。